Category: personalized medicine
-
Convergence Science Transforming Biomedicine, MIT Report says
“Convergence science has advanced across many fronts, from nanotechnology to regenerative tissue,” says Nobel Laureate Phil Sharp of MIT. “But the funding allocated for convergence research in biomedical science is small and needs to be expanded. In fact, there is no federal agency with the responsibility to fund convergence in biomedical research.”
-
Companies Receive $1.3 M in MA-Israeli Collaboration Grants
Four Boston area Israeli collaborations receive $1.3 in funding for innovative medical and energy projects under new MA/Israel partnership.
-
Pasteur Institute Spin-out Ariana Pharma Opens Cambridge Office; Analytics Tech to Streamline Clinical Trials
Anita Harris of New Cambridge Observer writes that Ariana Pharma opens Ariana Data Intelligence, Inc., in Cambridge. Ariana offers “KEM” non-statistical analysis technology to streamline and to cut financial risk of clinical trials.
-
Bio-IT World Review: BIG Data; BIG Promise; BIG CHALLENGES.
New Cambridge Observer’s Anita Harris on BIO-IT World 2012, describing the promise and problems presented by burgeoning of health care data.
-
Bob Langer: inspiration for job seekers
In a recent talk, MIT Institute Professor Bob Langer described the difficulties he faced in his early career. For job hunters out there the message is simple but profound. Believe in yourself and your ideas, treat people kindly, and keep on going. Great talk, Bob. Once again, bravo.
-
Non-invasive test predicts risk of sudden cardiac arrest
A meta-analysis and four additional studies published in the March 2009 Heart Rhythm journal show clearly that Cambridge Heart’s non-invasive MTWA test can accurately predicts the risk of sudden cardiac arrest–the leading killer in the US.